A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides

NCT02261467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Forehead Rhytides
Glabellar Rhytides

Interventions

BIOLOGICAL: OnabotulinumtoxinA
DRUG: Normal Saline

Sponsor

Allergan